Skip to main content
. 2016 Mar 7;30(6):869–878. doi: 10.1097/QAD.0000000000000988

Fig. 1.

Mean changes from baselinea in fasting metabolic parameters in each treatment group over the 48-week duration of the study.

Fig. 1

(a) Total cholesterol (b) triglycerides (c) LDL cholesterol (d) HDL cholesterol (safety population). BL, baseline; CVC, cenicriviroc; EFV, efavirenz; HDL, high-density lipoprotein; LDL, low-density lipoprotein; SE, standard error. aBaseline defined as the last nonmissing assessment prior to initiation of study treatment.